Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study

Authors:

Abstract
No abstract available
Funding Information
  • Merck

This publication has 24 references indexed in Scilit: